Global Orthopaedic Oncology Market Growth (Status and Outlook) 2018-2023


Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours.

According to this study, over the next five years the Orthopaedic Oncology market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in Orthopaedic Oncology business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Orthopaedic Oncology market by product type, application, key companies and key regions.

This study considers the Orthopaedic Oncology value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 10.7.



Targeted Therapy

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 10.8.


Research Laboratories

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.


United States








Southeast Asia










Middle East & Africa


South Africa



GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Stryker Corporation

Amgen Inc.

Creganna Medical Group

Accentus Inc.

Canon Medical Systems

Siemens Healthineers

MD Anderson Cancer Center

F. Hoffmann-La Roche Ltd.

Novartis AG

Sanofi S.A.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Orthopaedic Oncology market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Orthopaedic Oncology market by identifying its various subsegments.

Focuses on the key global Orthopaedic Oncology players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Orthopaedic Oncology with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Orthopaedic Oncology submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Orthopaedic Oncology Market Report (Status and Outlook)

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Orthopaedic Oncology Market Size 2013-2023

2.1.2 Orthopaedic Oncology Market Size CAGR by Region

2.2 Orthopaedic Oncology Segment by Type

2.2.1 Surgery

2.2.2 Chemotherapy

2.2.3 Radiation Therapy

2.2.4 Targeted Therapy

2.3 Orthopaedic Oncology Market Size by Type

2.3.1 Global Orthopaedic Oncology Market Size Market Share by Type (2013-2018)

2.3.2 Global Orthopaedic Oncology Market Size Growth Rate by Type (2013-2018)

2.4 Orthopaedic Oncology Segment by Application

2.4.1 Hospitals

2.4.2 Research Laboratories

2.5 Orthopaedic Oncology Market Size by Application

2.5.1 Global Orthopaedic Oncology Market Size Market Share by Application (2013-2018)

2.5.2 Global Orthopaedic Oncology Market Size Growth Rate by Application (2013-2018)

3 Global Orthopaedic Oncology by Players

3.1 Global Orthopaedic Oncology Market Size Market Share by Players

3.1.1 Global Orthopaedic Oncology Market Size by Players (2016-2018)

3.1.2 Global Orthopaedic Oncology Market Size Market Share by Players (2016-2018)

3.2 Global Orthopaedic Oncology Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Orthopaedic Oncology by Regions

4.1 Orthopaedic Oncology Market Size by Regions

4.2 Americas Orthopaedic Oncology Market Size Growth

4.3 APAC Orthopaedic Oncology Market Size Growth

4.4 Europe Orthopaedic Oncology Market Size Growth

4.5 Middle East & Africa Orthopaedic Oncology Market Size Growth

5 Americas

5.1 Americas Orthopaedic Oncology Market Size by Countries

5.2 Americas Orthopaedic Oncology Market Size by Type

5.3 Americas Orthopaedic Oncology Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries


6.1 APAC Orthopaedic Oncology Market Size by Countries

6.2 APAC Orthopaedic Oncology Market Size by Type

6.3 APAC Orthopaedic Oncology Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Orthopaedic Oncology by Countries

7.2 Europe Orthopaedic Oncology Market Size by Type

7.3 Europe Orthopaedic Oncology Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Orthopaedic Oncology by Countries

8.2 Middle East & Africa Orthopaedic Oncology Market Size by Type

8.3 Middle East & Africa Orthopaedic Oncology Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Orthopaedic Oncology Market Forecast

10.1 Global Orthopaedic Oncology Market Size Forecast (2018-2023)

10.2 Global Orthopaedic Oncology Forecast by Regions

10.2.1 Global Orthopaedic Oncology Forecast by Regions (2018-2023)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Orthopaedic Oncology Forecast by Type

10.8 Global Orthopaedic Oncology Forecast by Application

11 Key Players Analysis

11.1 Stryker Corporation

11.1.1 Company Details

11.1.2 Orthopaedic Oncology Product Offered

11.1.3 Stryker Corporation Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.1.4 Main Business Overview

11.1.5 Stryker Corporation News

11.2 Amgen Inc.

11.2.1 Company Details

11.2.2 Orthopaedic Oncology Product Offered

11.2.3 Amgen Inc. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.2.4 Main Business Overview

11.2.5 Amgen Inc. News

11.3 Creganna Medical Group

11.3.1 Company Details

11.3.2 Orthopaedic Oncology Product Offered

11.3.3 Creganna Medical Group Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.3.4 Main Business Overview

11.3.5 Creganna Medical Group News

11.4 Accentus Inc.

11.4.1 Company Details

11.4.2 Orthopaedic Oncology Product Offered

11.4.3 Accentus Inc. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.4.4 Main Business Overview

11.4.5 Accentus Inc. News

11.5 Canon Medical Systems

11.5.1 Company Details

11.5.2 Orthopaedic Oncology Product Offered

11.5.3 Canon Medical Systems Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.5.4 Main Business Overview

11.5.5 Canon Medical Systems News

11.6 Siemens Healthineers

11.6.1 Company Details

11.6.2 Orthopaedic Oncology Product Offered

11.6.3 Siemens Healthineers Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.6.4 Main Business Overview

11.6.5 Siemens Healthineers News

11.7 MD Anderson Cancer Center

11.7.1 Company Details

11.7.2 Orthopaedic Oncology Product Offered

11.7.3 MD Anderson Cancer Center Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.7.4 Main Business Overview

11.7.5 MD Anderson Cancer Center News

11.8 F. Hoffmann-La Roche Ltd.

11.8.1 Company Details

11.8.2 Orthopaedic Oncology Product Offered

11.8.3 F. Hoffmann-La Roche Ltd. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.8.4 Main Business Overview

11.8.5 F. Hoffmann-La Roche Ltd. News

11.9 Novartis AG

11.9.1 Company Details

11.9.2 Orthopaedic Oncology Product Offered

11.9.3 Novartis AG Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.9.4 Main Business Overview

11.9.5 Novartis AG News

11.10 Sanofi S.A.

11.10.1 Company Details

11.10.2 Orthopaedic Oncology Product Offered

11.10.3 Sanofi S.A. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.10.4 Main Business Overview

11.10.5 Sanofi S.A. News

12 Research Findings and Conclusion


Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


Our Clients

Some Facts about Fior Markets


Free Customization


Countries can be added on demand


Free yearly update on purchase of Multi/Corporate User License


Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.